Staphylococcus aureus: the “Superbug”

Michael Otto

doi:10.1128/9781555815479.ch16

Chapter 16 : Staphylococcus aureus: the “Superbug”

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840

Content Type: Monograph

Publication Year: 2009

Category: Food Microbiology; Applied and Industrial Microbiology

Book DOI: 10.1128/9781555815479

Chapter DOI: 10.1128/9781555815479.ch16

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Staphylococcus aureus: the “Superbug”, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815479/9781555814052_Chap16-1.gif /docserver/preview/fulltext/10.1128/9781555815479/9781555814052_Chap16-2.gif

Abstract:

This chapter provides a review of one's knowledge of immune defense mechanisms, with special emphasis on the recent emergence of community-associated antibiotic resistant strains. Two families of molecules have an especially important role in the colonization of human body surfaces: (i) bacterial surface-bound proteins that bind to human matrix proteins for a tight interaction with epithelial tissues and (ii) ion transporters that cope with the high-salt and low-pH environment of the skin. It is important to stress that innate host defense is most likely by far the most important part of host defense with the task of eliminating invading Staphylococcus aureus. S. aureus may survive in phagocytes over certain periods without lysing them. The immune evasion strategies described so far are rather ‘’passive’’; i.e., they either provide the pathogen with molecules necessary to survive under the hostile conditions encountered on or inside the human body, are aimed to hide from the immune system in a relatively benign fashion, or finally, sabotage mechanisms of the host that would kill S. aureus. First reported to occur in children in the northwestern United States, CA-MRSA has spread with astounding speed. The molecular reason for which community associated methicillin-resistant S. aureus (CA-MRSA) and especially USA300 are so much more infective than their hospital-associated counterparts is still puzzling researchers.

Citation: Otto M. 2009. Staphylococcus aureus: the “Superbug”, p 297-309. In Jaykus L, Wang H, Schlesinger L (ed), Food-Borne Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555815479.ch16

Highlighted Text: Show | Hide

Full text loading...

References

/content/book/10.1128/9781555815479.ch16

1. Anonymous. 1999. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. JAMA 282: 1123– 1125.

2. Anonymous. 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32: 470– 485.

3. Bader, M. W.,, S. Sanowar,, M. E. Daley,, A. R. Schneider,, U. Cho,, W. Xu,, R. E. Klevit,, H. Le Moual, and, S. I. Miller. 2005. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122: 461– 472.

4. Beenken, K. E.,, P. M. Dunman,, F. McAleese,, D. Macapagal,, E. Murphy,, S. J. Projan,, J. S. Blevins, and, M. S. Smeltzer. 2004. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186: 4665– 4684.

5. Bhakdi, S., and, J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55: 733– 751.

6. Bohach, G. A.,, D. J. Fast,, R. D. Nelson, and, P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17: 251– 272.

7. Chambers, H. F. 2005. Community-associated MRSA—resistance and virulence converge. N. Engl. J. Med. 352: 1485– 1487.

8. Cook, H. A.,, E. Y. Furuya,, E. Larson,, G. Vasquez, and, F. D. Lowy. 2007. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 44: 410– 413.

9. Costerton, J. W.,, Z. Lewandowski,, D. E. Caldwell,, D. R. Korber, and, H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49: 711– 745.

10. Costerton, J. W.,, P. S. Stewart, and, E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284: 1318– 1322.

11. Cramton, S. E.,, C. Gerke,, N. F. Schnell,, W. W. Nichols, and, F. Gotz. 1999. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67: 5427– 5433.

12. de Haas, C. J.,, K. E. Veldkamp,, A. Peschel,, F. Weerkamp,, W. J. Van Wamel,, E. C. Heezius,, M. J. Poppelier,, K. P. Van Kessel, and, J. A. van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199: 687– 695.

13. de Lencastre, H.,, D. Oliveira, and, A. Tomasz. 2007. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr. Opin. Microbiol. 10: 428– 435.

14. Deleo, F. R., and, M. Otto. 2008. An antidote for Staphylococcus aureus pneumonia? J. Exp. Med. 205: 271– 274. (Erratum, 205: 739.)

15. Diep, B. A.,, H. F. Chambers,, C. J. Graber,, J. D. Szumowski,, L. G. Miller,, L. L. Han,, J. H. Chen,, F. Lin,, J. Lin,, T. H. Phan,, H. A. Carleton,, L. K. McDougal,, F. C. Tenover,, D. E. Cohen,, K. H. Mayer,, G. F. Sensabaugh, and, F. Perdreau-Remington. 2008. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148: 249– 257.

16. Diep, B. A.,, S. R. Gill,, R. F. Chang,, T. H. Phan,, J. H. Chen,, M. G. Davidson,, F. Lin,, J. Lin,, H. A. Carleton,, E. F. Mongodin,, G. F. Sensabaugh, and, F. Perdreau-Remington. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367: 731– 739.

17. Dinges, M. M.,, P. M. Orwin, and, P. M. Schlievert. 2000. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13: 16– 34.

18. Fedtke, I.,, D. Mader,, T. Kohler,, H. Moll,, G. Nicholson,, R. Biswas,, K. Henseler,, F. Gotz,, U. Zahringer, and, A. Peschel. 2007. A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol. Microbiol. 65: 1078– 1091.

19. Fischer, W.,, P. Rosel, and, H. U. Koch. 1981. Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus. J. Bacteriol. 146: 467– 475.

20. Forsgren, A., and, K. Nordstrom. 1974. Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann. N. Y. Acad. Sci. 236: 252– 266.

21. Foster, T. J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948– 958.

22. Foster, T. J., and, M. Hook. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6: 484– 488.

23. Fowler, V. G., Jr.,, G. Sakoulas,, L. M. McIntyre,, V. G. Meka,, R. D. Arbeit,, C. H. Cabell,, M. E. Stryjewski,, G. M. Eliopoulos,, L. B. Reller,, G. R. Corey,, T. Jones,, N. Lucindo,, M. R. Yeaman, and, A. S. Bayer. 2004. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190: 1140– 1149.

24. Gill, S. R.,, D. E. Fouts,, G. L. Archer,, E. F. Mongodin,, R. T. Deboy,, J. Ravel,, I. T. Paulsen,, J. F. Kolonay,, L. Brinkac,, M. Beanan,, R. J. Dodson,, S. C. Daugherty,, R. Madupu,, S. V. Angiuoli,, A. S. Durkin,, D. H. Haft,, J. Vamathevan,, H. Khouri,, T. Utterback,, C. Lee,, G. Dimitrov,, L. Jiang,, H. Qin,, J. Weidman,, K. Tran,, K. Kang,, I. R. Hance,, K. E. Nelson, and, C. M. Fraser. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187: 2426– 2438.

25. Gillet, Y.,, B. Issartel,, P. Vanhems,, J. C. Fournet,, G. Lina,, M. Bes,, F. Vandenesch,, Y. Piemont,, N. Brousse,, D. Floret, and, J. Etienne. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753– 759.

26. Goerke, C.,, M. Kummel,, K. Dietz, and, C. Wolz. 2003. Evaluation of intraspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization. J. Infect. Dis. 188: 250– 256.

27. Gomez, M. I.,, A. Lee,, B. Reddy,, A. Muir,, G. Soong,, A. Pitt,, A. Cheung, and, A. Prince. 2004. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 10: 842– 848.

28. Gresham, H. D.,, J. H. Lowrance,, T. E. Caver,, B. S. Wilson,, A. L. Cheung, and, F. P. Lindberg. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164: 3713– 3722.

29. Gross, M.,, S. E. Cramton,, F. Gotz, and, A. Peschel. 2001. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect. Immun. 69: 3423– 3426.

30. Hancock, R. E., and, G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8: 402– 410.

31. Harder, J., and, J. M. Schroder. 2005. Antimicrobial peptides in human skin. Chem. Immunol. Allergy 86: 22– 41.

32. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1: 147– 155.

33. Huseby, M.,, K. Shi,, C. K. Brown,, J. Digre,, F. Mengistu,, K. S. Seo,, G. A. Bohach,, P. M. Schlievert,, D. H. Ohlendorf, and, C. A. Earhart. 2007. Structure and biological activities of beta toxin from Staphylococcus aureus. J. Bacteriol. 189: 8719– 8726.

34. Jensen, K. 1958. A normally occurring Staphylococcus antibody in human serum. Acta Pathol. Microbiol. Scand. 44: 421– 428.

35. Jonsson, K.,, D. McDevitt,, M. H. McGavin,, J. M. Patti, and, M. Hook. 1995. Staphylococcus aureus expresses a major histocompatibility complex class II analog. J. Biol. Chem. 270: 21457– 21460.

36. Josefsson, E.,, K. W. McCrea,, D. Ni Eidhin,, D. O’Connell,, J. Cox,, M. Hook, and, T. J. Foster. 1998. Three new members of the serineaspartate repeat protein multigene family of Staphylococcus aureus. Microbiology 144( Pt. 12) : 3387– 3395.

37. Kaneko, J., and, Y. Kamio. 2004. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci. Biotechnol. Biochem. 68: 981– 1003.

38. Kazakova, S. V.,, J. C. Hageman,, M. Matava,, A. Srinivasan,, L. Phelan,, B. Garfinkel,, T. Boo,, S. McAllister,, J. Anderson,, B. Jensen,, D. Dodson,, D. Lonsway,, L. K. McDougal,, M. Arduino,, V. J. Fraser,, G. Killgore,, F. C. Tenover,, S. Cody, and, D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352: 468– 475.

39. Kennedy, A. D.,, M. Otto,, K. R. Braughton,, A. R. Whitney,, L. Chen,, B. Mathema,, J. R. Mediavilla,, K. A. Byrne,, L. D. Parkins,, F. C. Tenover,, B. N. Kreiswirth,, J. M. Musser, and, F. R. DeLeo. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc. Natl. Acad. Sci. USA 105: 1327– 1332.

40. Kiem, S.,, W. S. Oh,, K. R. Peck,, N. Y. Lee,, J. Y. Lee,, J. H. Song,, E. S. Hwang,, E. C. Kim,, C. Y. Cha, and, K. W. Choe. 2004. Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface. J. Korean Med. Sci. 19: 779– 782.

41. Kloos, W., and, K. H. Schleifer. 1986. Staphylococcus, p. 1013– 1035. In P. H. A. Sneath,, N. S. Mair,, M. E. Sharpe, and, J. G. Holt (ed.), Bergey’s Manual of Systematic Bacteriology, vol. 2. Williams & Wilkins, Baltimore, MD.

42. Kong, K. F.,, C. Vuong, and, M. Otto. 2006. Staphylococcus quorum sensing in biofilm formation and infection. Int. J. Med. Microbiol. 296: 133– 139.

43. Kreikemeyer, B.,, D. McDevitt, and, A. Podbielski. 2002. The role of the Map protein in Staphylococcus aureus matrix protein and eukaryotic cell adherence. Int. J. Med. Microbiol. 292: 283– 295.

44. Kubica, M.,, K. Guzik,, J. Koziel,, M. Zarebski,, W. Richter,, B. Gajkowska,, A. Golda,, A. Maciag-Gudowska,, K. Brix,, L. Shaw,, T. Foster, and, J. Potempa. 2008. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 3: e1409.

45. Lai, Y.,, A. E. Villaruz,, M. Li,, D. J. Cha,, D. E. Sturdevant, and, M. Otto. 2007. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 63: 497– 506.

46. Langone, J. J. 1982. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumococci. Adv. Immunol. 32: 157– 252.

47. Lappin-Scott, H. M., and, C. Bass. 2001. Biofilm formation: attachment, growth, and detachment of microbes from surfaces. Am. J. Infect. Control 29: 250– 251.

48. Le Loir, Y.,, F. Baron, and, M. Gautier. 2003. Staphylococcus aureus and food poisoning. Genet. Mol. Res. 2: 63– 76.

49. Li, M.,, D. J. Cha,, Y. Lai,, A. E. Villaruz,, D. E. Sturdevant, and, M. Otto. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 66: 1136– 1147.

50. Li, M.,, Y. Lai,, A. E. Villaruz,, D. J. Cha,, D. E. Sturdevant, and, M. Otto. 2007. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl. Acad. Sci. USA 104: 9469– 9474.

51. Lindsay, J. A., and, T. V. Riley. 1994. Staphylococcal iron requirements, siderophore production, and iron-regulated protein expression. Infect. Immun. 62: 2309– 2314.

52. Liu, C. I.,, G. Y. Liu,, Y. Song,, F. Yin,, M. E. Hensler,, W. Y. Jeng,, V. Nizet,, A. H. Wang, and, E. Oldfield. 2008. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319: 1391– 1394.

53. Liu, G. Y.,, A. Essex,, J. T. Buchanan,, V. Datta,, H. M. Hoffman,, J. F. Bastian,, J. Fierer, and, V. Nizet. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202: 209– 215.

54. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520– 532.

55. Mack, D.,, W. Fischer,, A. Krokotsch,, K. Leopold,, R. Hartmann,, H. Egge, and, R. Laufs. 1996. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178: 175– 183.

56. Marraffini, L. A.,, A. C. Dedent, and, O. Schneewind. 2006. Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol. Mol. Biol. Rev. 70: 192– 221.

57. Mazmanian, S. K.,, G. Liu,, H. Ton-That, and, O. Schneewind. 1999. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285: 760– 763.

58. Mazmanian, S. K.,, E. P. Skaar,, A. H. Gaspar,, M. Humayun,, P. Gornicki,, J. Jelenska,, A. Joachmiak,, D. M. Missiakas, and, O. Schneewind. 2003. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299: 906– 909.

59. McCormick, J. K.,, J. M. Yarwood, and, P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55: 77– 104.

60. Miller, L. G., and, B. A. Diep. 2008. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46: 752– 760.

61. Moran, G. J.,, A. Krishnadasan,, R. J. Gorwitz,, G. E. Fosheim,, L. K. McDougal,, R. B. Carey, and, D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355: 666– 674.

62. Navarre, W. W., and, O. Schneewind. 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63: 174– 229.

63. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48: 1429– 1449.

64. O’Riordan, K., and, J. C. Lee. 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17: 218– 234.

65. Otto, M. 2004. Virulence factors of the coagulase-negative staphylococci. Front. Biosci. 9: 841– 863.

66. Otto, M.,, H. Echner,, W. Voelter, and, F. Gotz. 2001. Pheromone cross-inhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 69: 1957– 1960.

67. Patti, J. M.,, B. L. Allen,, M. J. McGavin, and, M. Hook. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48: 585– 617.

68. Pelz, A.,, K. P. Wieland,, K. Putzbach,, P. Hentschel,, K. Albert, and, F. Götz. 2005. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 280: 32493– 32498.

69. Peschel, A. 2002. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10: 179– 186.

70. Peschel, A.,, R. W. Jack,, M. Otto,, L. V. Collins,, P. Staubitz,, G. Nicholson,, H. Kalbacher,, W. F. Nieuwenhuizen,, G. Jung,, A. Tarkowski,, K. P. van Kessel, and, J. A. van Strijp. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193: 1067– 1076.

71. Peschel, A.,, M. Otto,, R. W. Jack,, H. Kalbacher,, G. Jung, and, F. Gotz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274: 8405– 8410.

72. Peschel, A., and, H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4: 529– 536.

73. Pillar, C. M.,, D. C. Draghi,, D. J. Sheehan, and, D. F. Sahm. 2008. Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs. Diagn. Microbiol. Infect. Dis. 60: 221– 224.

74. Prat, C.,, J. Bestebroer,, C. J. de Haas,, J. A. van Strijp, and, K. P. van Kessel. 2006. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J. Immunol. 177: 8017– 8026.

75. Recsei, P.,, B. Kreiswirth,, M. O’Reilly,, P. Schlievert,, A. Gruss, and, R. P. Novick. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol. Gen. Genet. 202: 58– 61.

76. Rice, K. C.,, E. E. Mann,, J. L. Endres,, E. C. Weiss,, J. E. Cassat,, M. S. Smeltzer, and, K. W. Bayles. 2007. The CidA murein hydro-lase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 104: 8113– 8118.

77. Richmond, M. H. 1979. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story. Rev. Infect. Dis. 1: 30– 38.

78. Rooijakkers, S. H.,, M. Ruyken,, A. Roos,, M. R. Daha,, J. S. Presanis,, R. B. Sim,, W. J. van Wamel,, K. P. van Kessel, and, J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920– 927.

79. Rooijakkers, S. H.,, K. P. van Kessel, and, J. A. van Strijp. 2005. Staphylococcal innate immune evasion. Trends Microbiol. 13: 596– 601.

80. Rooijakkers, S. H.,, W. J. van Wamel,, M. Ruyken,, K. P. van Kessel, and, J. A. van Strijp. 2005. Anti-opsonic properties of staphylokinase. Microbes Infect. 7: 476– 484.

81. Sakoulas, G.,, G. M. Eliopoulos,, R. C. Moellering, Jr.,, R. P. Novick,, L. Venkataraman,, C. Wennersten,, P. C. DeGirolami,, M. J. Schwaber, and, H. S. Gold. 2003. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J. Infect. Dis. 187: 929– 938.

82. Schittek, B.,, R. Hipfel,, B. Sauer,, J. Bauer,, H. Kalbacher,, S. Stevanovic,, M. Schirle,, K. Schroeder,, N. Blin,, F. Meier,, G. Rassner, and, C. Garbe. 2001. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2: 1133– 1137.

83. Shiau, A. L., and, C. L. Wu. 1998. The inhibitory effect of Staphylococcus epidermidis slime on the phagocytosis of murine peritoneal macrophages is interferon-independent. Microbiol. Immunol. 42: 33– 40.

84. Sieprawska-Lupa, M.,, P. Mydel,, K. Krawczyk,, K. Wojcik,, M. Puklo,, B. Lupa,, P. Suder,, J. Silberring,, M. Reed,, J. Pohl,, W. Shafer,, F. McAleese,, T. Foster,, J. Travis, and, J. Potempa. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48: 4673– 4679.

85. Sievert, D. M.,, J. T. Rudrik,, J. B. Patel,, L. C. McDonald,, M. J. Wilkins, and, J. C. Hageman. 2008. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin. Infect. Dis. 46: 668– 674.

86. Somerville, G. A.,, S. B. Beres,, J. R. Fitzgerald,, F. R. DeLeo,, R. L. Cole,, J. S. Hoff, and, J. M. Musser. 2002. In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J. Bacteriol. 184: 1430– 1437.

87. Ton-That, H.,, S. K. Mazmanian,, K. F. Faull, and, O. Schneewind. 2000. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH 2-Gly 3substrates. J. Biol. Chem. 275: 9876– 9881.

88. Torres, V. J.,, G. Pishchany,, M. Humayun,, O. Schneewind, and, E. P. Skaar. 2006. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J. Bacteriol. 188: 8421– 8429.

89. Valeva, A.,, I. Walev,, M. Pinkernell,, B. Walker,, H. Bayley,, M. Palmer, and, S. Bhakdi. 1997. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc. Natl. Acad. Sci. USA 94: 11607– 11611.

90. Voyich, J. M.,, K. R. Braughton,, D. E. Sturdevant,, A. R. Whitney,, B. Said-Salim,, S. F. Porcella,, R. D. Long,, D. W. Dorward,, D. J. Gardner,, B. N. Kreiswirth,, J. M. Musser, and, F. R. DeLeo. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175: 3907– 3919.

91. Voyich, J. M.,, M. Otto,, B. Mathema,, K. R. Braughton,, A. R. Whitney,, D. Welty,, R. D. Long,, D. W. Dorward,, D. J. Gardner,, G. Lina,, B. N. Kreiswirth, and, F. R. DeLeo. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194: 1761– 1770.

92. Vuong, C.,, S. Kocianova,, Y. Yao,, A. B. Carmody, and, M. Otto. 2004. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 190: 1498– 1505.

93. Vuong, C.,, H. L. Saenz,, F. Gotz, and, M. Otto. 2000. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182: 1688– 1693.

94. Vuong, C.,, J. M. Voyich,, E. R. Fischer,, K. R. Braughton,, A. R. Whitney,, F. R. DeLeo, and, M. Otto. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6: 269– 275.

95. Wang, R.,, K. R. Braughton,, D. Kretschmer,, T. H. Bach,, S. Y. Queck,, M. Li,, A. D. Kennedy,, D. W. Dorward,, S. J. Klebanoff,, A. Peschel,, F. R. Deleo, and, M. Otto. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13: 1510– 1514.

96. Wardenburg, J. B.,, T. Bae,, M. Otto,, F. R. Deleo, and, O. Schneewind. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13: 1405– 1406.

97. Wardenburg, J. B., and, O. Schneewind. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205: 287– 294.

98. Yao, Y.,, D. E. Sturdevant, and, M. Otto. 2005. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J. Infect. Dis. 191: 289– 298.